Cipla (LUX:CIPLA) Non Operating Income: $0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LUX:CIPLA Cipla Ltd LUX:CIPLA
83 GF Score
Price $18.10
GF Value $19.34
! 5 Warning Signs
View Full Analysis

What is Cipla Non Operating Income?

Cipla LUX:CIPLA 83 Non Operating Income is $0 Mil as of Jun. 2026. GuruFocus rates LUX:CIPLA with a GF Score™ of 83/100 and a GF Value™ of $19.34. The stock has 5 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Cipla's Non Operating Income for the three months ended in Jun. 2026 was $0 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was $0 Mil.

Cipla Non Operating Income Related Terms

Cipla Non Operating Income Historical Data

* Premium members only.

The historical data trend for Cipla's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla Non Operating Income Chart

Cipla Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cipla Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LUX:CIPLA
83GF Score
Cipla Ltd LUX:CIPLA
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipla Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of $0 Mil mean?
Cipla (LUX:CIPLA) has a Non Operating Income of $0 Mil as of Jun. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Cipla and its competitors.
Is Cipla's Non Operating Income too high?
Cipla's current Non Operating Income is $0 Mil. Overall, Cipla has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Cipla's Non Operating Income compare to ZTS?
Cipla's Non Operating Income of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Drug Manufacturers company?
A good Non Operating Income depends on the Drug Manufacturers industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Cipla and its competitors. Cipla's current Non Operating Income is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipla stock overvalued right now?
Cipla (LUX:CIPLA) has a current Non Operating Income of $0 Mil. The stock's GF Value™ is $19.34, compared to a current price of $18.10 — trading 6.4% below its estimated fair value. The current Non Operating Income is $0 Mil. Cipla's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Cipla (LUX:CIPLA), the current Non Operating Income is $0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipla (LUX:CIPLA) Overvalued in 2026?

Based on GuruFocus' analysis, Cipla stock appears to be undervalued. The current stock price of $18.10 is trading 6.4% below its estimated GF Value™ of $19.34.

Key valuation signals for LUX:CIPLA:

  • Non Operating Income: $0 Mil
  • GF Value™: $19.34 vs. price of $18.10 (6.4% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the LUX:CIPLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipla Business Description

Other Exchanges CIPLA:India500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
83GF Score

Get the complete analysis for LUX:CIPLA

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.10
Price
$19.34
GF Value